MedPath

Lyric Self-replacement Clinical Investigation

Not Applicable
Completed
Conditions
Hearing Loss
Interventions
Device: Phonak Lyric self-replacement procedure
Registration Number
NCT05349981
Lead Sponsor
Sonova AG
Brief Summary

This study is designed to investigate the effectiveness and safety of the Phonak Lyric self-replacement procedure, as compared to the HCP-replacement procedure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • Meets requirements outlined on Lyric self-replacement candidacy form
  • Current Lyric hearing instrument user with 3+ months of Lyric experience
  • 22 years of age or older at the time of enrollment in the study
  • Mild-to-moderately severe sensorineural hearing loss (bilaterally or unilaterally)
  • Good understanding (read/write/speak) of the English language
  • Willingness to comply with all study requirements
Exclusion Criteria
  • Does not meet requirements outlined on Lyric self-replacement candidacy form
  • Difficulty understanding/reading instructions when corrected for vision loss
  • Impairments that would restrict participation in any of the evaluations
  • Ear health conditions present at baseline that prevent immediate device replacement
  • Conditions that would indicate the need for medical referral prior to hearing aid fitting according to local regulations

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lyric self-replacementPhonak Lyric self-replacement procedureThis cohort of experienced Lyric patients are required to meet the candidacy criteria to be eligible for the self-replacement procedure. They will also be required to demonstrate proficiency with the self-replacement procedure before proceeding with independent self-replacement.
Primary Outcome Measures
NameTimeMethod
Change in aided audiometric threshold testing between standard and experimental replacement proceduresBaseline, during intervention, immediately after intervention

Aided audiometric test measures: threshold testing. Thresholds will be measured in decibels Hearing Level (dBHL), with a range of -10 - 120 dBHL. Lower scores indicate better performance. Change in scores will be assessed between standard and experimental replacement procedures.

Change in aided speech-in-noise testing between standard and experimental replacement proceduresBaseline, during intervention, immediately after intervention

Aided audiometric test measures: speech-in-noise testing. Scores will be measured using signal-to-noise ratio loss, with scores ranging from 0 - 25.5. Lower scores indicate better performance. Change in scores will be assessed between standard and experimental replacement procedures.

Secondary Outcome Measures
NameTimeMethod
Change in incidence of medical referrals secondary to device replacement procedure-related ear health outcome between standard and experimental replacement proceduresThrough study completion, an average of 5 months

Evaluation of incidence of medical referral secondary to device replacement, as determined necessary by the hearing care professional, and compared between the standard and experimental device replacement procedures

Trial Locations

Locations (7)

Aim Hearing and Audiology

๐Ÿ‡บ๐Ÿ‡ธ

Greensboro, North Carolina, United States

San Francisco Audiology

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

NYC Hearing Associates

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Bay Area Audiology and Hearing Aids

๐Ÿ‡บ๐Ÿ‡ธ

Webster, Texas, United States

ENT & Audiology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

The Woodlands Hearing Center

๐Ÿ‡บ๐Ÿ‡ธ

The Woodlands, Texas, United States

Richmond Hearing Doctors

๐Ÿ‡บ๐Ÿ‡ธ

Richmond, Virginia, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath